Preventing neonatal HIV: A review

被引:10
作者
Jaspan, HB [1 ]
Garry, RF [1 ]
机构
[1] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70119 USA
关键词
HIV; vertical transmission; antiretroviral prophylaxis; breast-feeding;
D O I
10.2174/1570162033485221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mother-to-child transmission of human immunodeficiency virus type I has become rare in developed countries, with the use of highly active antiretroviral treatment, elective cesarean section, and avoidance of breastfeeding. In the developing world, however, these interventions are unfeasible, and cost-saving methods for prevention of vertical transmission are vital. Prevention begins with voluntary counseling and testing, improved maternal education and access to prenatal care. Various antiretroviral drugs administered before, during, and for short periods after delivery have decreased vertical transmission. Where safe and compliant formula feeding is difficult, avoidance of mixed feeding may improve infant outcomes. However, post-natal transmission via breast milk remains a major challenge. As we continue to find cost-effective answers to protect infants worldwide, the search for a HIV-1 vaccine continues.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 47 条
[1]  
BEOCKLEHURST P, 2002, COCHRANE LIB
[2]  
*BHIVA, 2001, HIV MED, V2, P276
[3]   Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines [J].
Borkowsky, W ;
Wara, D ;
Fenton, T ;
McNamara, J ;
Kang, MH ;
Mofenson, L ;
McFarland, E ;
Cunningham, C ;
Duliege, AM ;
Francis, D ;
Bryson, Y ;
Burchett, S ;
Spector, SA ;
Frenkel, LM ;
Starr, S ;
Van Dyke, R ;
Jimenez, E .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :890-896
[4]  
BROCKLEHURST P, 2002, COCHRANE LIB
[5]  
*CDC, 1995, MMWR-MORBID MORTAL W, V44, P929
[6]   Protease inhibitors and decreased birth weight in HIV-infected pregnant women with impaired glucose tolerance [J].
Chmait R. ;
Franklin P. ;
Spector S.A. ;
Hull A.D. .
Journal of Perinatology, 2002, 22 (5) :370-373
[7]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[8]  
Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009
[9]   Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study [J].
Coutsoudis, A ;
Pillay, K ;
Spooner, E ;
Kuhn, L ;
Coovadia, HM .
LANCET, 1999, 354 (9177) :471-476
[10]   6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso:: a double-blind placebo-controlled multicentre trial [J].
Dabis, F ;
Msellati, P ;
Meda, N ;
Welffens-Ekra, C ;
You, B ;
Manigart, O ;
Leroy, V ;
Simonon, A ;
Cartoux, M ;
Combe, P ;
Ouangré, A ;
Ramon, R ;
Ky-Zerbo, O ;
Montcho, C ;
Salamon, R ;
Rouzioux, C ;
Van de Perre, P ;
Mandelbrot, L .
LANCET, 1999, 353 (9155) :786-792